Showing results (61-70 of 272) with videos related to
Sort By:
Pageof 28
Frontiers of Hormone Research|May 24, 2016
Skeletal Fragility in Endogenous HypercortisolismGherardo Mazziotti, Adriano Delgado, Filippo Maffezzoni, et al.Expert Opinion on Pharmacotherapy|October 26, 2017
Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspectsGherardo Mazziotti, Alessandra Mosca, Stefano Frara, et al.Expert Opinion on Investigational Drugs|July 26, 2014
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumorsAndrea Giustina, Gherardo Mazziotti, Filippo Maffezzoni, et al.Trends in Endocrinology and Metabolism: TEM|December 2, 2014
Growth hormone deficiency in treated acromegalyGherardo Mazziotti, Paolo Marzullo, Mauro Doga, et al.Endocrine Reviews|January 16, 2014
Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implicationsPeter Kamenický, Gherardo Mazziotti, Marc Lombès, et al.BMC Health Services Research|March 8, 2023
Patient characteristics associated with the acceptability of teleconsultation: a retrospective study of osteoporotic patients post-COVID-19Benedetta Pongiglione, Flaminia Carrone, Alessandra Angelucci, et al.Bone|November 7, 2009
Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral densityGherardo Mazziotti, Teresa Porcelli, Ilaria Patelli, et al.The Journal of Biological Chemistry|December 7, 2010
Reciprocal regulation of Notch and nuclear factor of activated T-cells (NFAT) c1 transactivation in osteoblastsStefano Zanotti, Anna Smerdel-Ramoya, Ernesto CanalisExpert Opinion on Pharmacotherapy|June 29, 2016
Current and future medical treatments for patients with acromegalyFilippo Maffezzoni, Anna Maria Formenti, Gherardo Mazziotti, et al.The Journal of Biological Chemistry|November 19, 2010
HES1 (hairy and enhancer of split 1) is a determinant of bone massStefano Zanotti, Anna Smerdel-Ramoya, Ernesto CanalisPageof 28